日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Glaucoma Risk Reduction as a Secondary Benefit of Glucagon-like Peptide-1 Receptor Agonists: A Review of Emerging Evidence

胰高血糖素样肽-1受体激动剂的次要获益：降低青光眼风险：新兴证据综述

期刊:Journal of Current Glaucoma Practice
影响因子:
doi:10.5005/jp-journals-10078-1501
Lang, Mary V; Vasu, Pranav; Dorairaj, Emily A; Bhartiya, Shibal; Dorairaj, Syril K
信号转导
神经科学
青光眼
发表日期：2025
文献求助 收藏

The Utility of Virtual Reality in Ophthalmology: A Review

虚拟现实技术在眼科领域的应用：综述

期刊:
影响因子:
doi:10.2147/OPTH.S517974
Ahuja, Abhimanyu S; Paredes Iii, Alfredo A; Eisel, Mallory L S; Ahuja, Sejal A; Wagner, Isabella V; Vasu, Pranav; Dorairaj, Syril; Miller, Darby; Abubaker, Yazan
发表日期：2025
文献求助 收藏

Temperature-Controlled Radiofrequency Neurolysis for the Treatment of Rhinitis

温控射频神经消融术治疗鼻炎

期刊:American Journal of Rhinology & Allergy
影响因子:2.3
doi:10.1177/19458924211033400
Ehmer, Dale; McDuffie, Chad M; Scurry, W Cooper Jr; McIntyre, J Bradley; Mehendale, Neelesh H; Willis, John H; Shealy, Ronald B; Watkins, Jeremy P; Kakarlapudi, V Vasu
鼻炎
发表日期：2022
文献求助 收藏

Long-term Outcomes Following Temperature-Controlled Radiofrequency Neurolysis for the Treatment of Chronic Rhinitis

温度控制射频神经消融术治疗慢性鼻炎的长期疗效

期刊:
影响因子:
doi:10.1177/21526575221096045
Ehmer, Dale; McDuffie, Chad M; McIntyre, J Bradley; Davis, Bryan M; Mehendale, Neelesh H; Willis, John H; Watkins, Jeremy P; Kakarlapudi, V Vasu
鼻炎
发表日期：2022
文献求助 收藏

Synthesis, Antiinflammatory and HIV-1 Integrase Inhibitory Activities of 1,2-Bis[5-thiazolyl]ethane-1,2-dione Derivatives

1,2-双[5-噻唑基]乙烷-1,2-二酮衍生物的合成、抗炎活性和HIV-1整合酶抑制活性

期刊:Indian Journal of Pharmaceutical Sciences
影响因子:0.4
doi:10.4103/0250-474X.56021
Franklin, P X; Yerande, S; Thakar, H M; Inamdar, G S; Giri, R S; Padh, H; Sudarsanam, V; Vasu, Kamala K
HIV
微生物学
发表日期：2009
文献求助 收藏